These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 10591480

  • 21. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.
    Brain Res Bull; 2006 Mar 31; 69(2):204-13. PubMed ID: 16533671
    [Abstract] [Full Text] [Related]

  • 22. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO.
    J Clin Psychopharmacol; 2002 Dec 31; 22(6):615-20. PubMed ID: 12454562
    [Abstract] [Full Text] [Related]

  • 23. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066.
    Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR.
    Neuropharmacology; 1999 Jan 31; 38(1):181-93. PubMed ID: 10193909
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex.
    Messamore E, Warpman U, Ogane N, Giacobini E.
    Neuropharmacology; 1993 Aug 31; 32(8):745-50. PubMed ID: 8413838
    [Abstract] [Full Text] [Related]

  • 26. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
    Cheng DH, Tang XC.
    Pharmacol Biochem Behav; 1998 Jun 31; 60(2):377-86. PubMed ID: 9632220
    [Abstract] [Full Text] [Related]

  • 27. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z.
    Acta Biol Hung; 2003 Jun 31; 54(2):183-9. PubMed ID: 14535624
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of novel 7-MEOTA-donepezil like hybrids and N-alkylated tacrine analogues in the treatment of quinuclidinyl benzilate-induced behavioural deficits in rats performing the multiple T-maze test.
    Misik J, Korabecny J, Nepovimova E, Cabelova P, Kassa J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec 31; 159(4):547-53. PubMed ID: 25690521
    [Abstract] [Full Text] [Related]

  • 30. The pharmacology of donepezil: a new treatment of Alzheimer's disease.
    Wilkinson DG.
    Expert Opin Pharmacother; 1999 Nov 31; 1(1):121-35. PubMed ID: 11249555
    [Abstract] [Full Text] [Related]

  • 31. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
    Gawel K, Labuz K, Gibula-Bruzda E, Jenda M, Marszalek-Grabska M, Filarowska J, Silberring J, Kotlinska JH.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct 31; 389(10):1059-71. PubMed ID: 27376896
    [Abstract] [Full Text] [Related]

  • 32. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
    Saxena G, Singh SP, Agrawal R, Nath C.
    Eur J Pharmacol; 2008 Mar 10; 581(3):283-9. PubMed ID: 18234183
    [Abstract] [Full Text] [Related]

  • 33. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
    Inglis F.
    Int J Clin Pract Suppl; 2002 Jun 10; (127):45-63. PubMed ID: 12139367
    [Abstract] [Full Text] [Related]

  • 34. Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats.
    Xu AJ, Chen Z, Yanai K, Huang YW, Wei EQ.
    Neurosci Lett; 2002 Oct 04; 331(1):33-6. PubMed ID: 12359317
    [Abstract] [Full Text] [Related]

  • 35. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation.
    Akasofu S, Kosasa T, Kimura M, Kubota A.
    Eur J Pharmacol; 2003 Jul 04; 472(1-2):57-63. PubMed ID: 12860473
    [Abstract] [Full Text] [Related]

  • 36. Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
    Lazartigues E, Freslon JL, Tellioglu T, Brefel-Courbon C, Pelat M, Tran MA, Montastruc JL, Rascol O.
    Eur J Pharmacol; 1998 Nov 13; 361(1):61-71. PubMed ID: 9851542
    [Abstract] [Full Text] [Related]

  • 37. [Pharmacological properties of donepezil hydrochloride (Aricept), a drug for Alzheimer's disease].
    Ogura H, Kosasa T, Araki S, Yamanishi Y.
    Nihon Yakurigaku Zasshi; 2000 Jan 13; 115(1):45-51. PubMed ID: 10876815
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    Caricati-Neto A, D'angelo LC, Reuter H, Hyppolito Jurkiewicz N, Garcia AG, Jurkiewicz A.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):191-201. PubMed ID: 15496314
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
    Wang H, Tang XC.
    Zhongguo Yao Li Xue Bao; 1998 Jan 25; 19(1):27-30. PubMed ID: 10375753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.